Sebastian Preissl

Dr.
Principal Investigator
(Associated Member)

Institute of Experimental and Clinical Pharmacology and Toxicology
University of Freiburg
Albertstr. 25
79104 Freiburg

Current Position

Deputy Professor, Group Leader

Academic Education

2010 German licensure as pharmacist
2009 - 2010 Diploma in Pharmacy, European ScreeningPort GmbH, Hamburg, Germany and Institute for Pharmaceutical Sciences, University of Freiburg, Germany
2004 - 2009 Study of Pharmacy, University of Freiburg, Germany

Advanced Qualifications

2010-2015 PhD, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany

Postgraduate Positions

2021 - present Deputy Professor, Group Leader, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany
2017-2021 Associate Director, Single Cell Genomics, Center for Epigenomics, UCSD, La Jolla, CA, USA
2015-2017 Postdoctoral Fellow, Ludwig Institute for Cancer Research, La Jolla, CA, USA
2015 Postdoctoral Fellow, Institute of Experimental and Clinical Pharmacology and Toxicology, University of Freiburg, Germany

Link to all publications of Sebastian Preissl: PubMed

Publications on CRC 1453 funding

Mahajan A, Spracklen CN, Zhang W, Ng MCY, Petty LE, …, Wuttke M, …, Preissl S, …, Köttgen A, …, Rotter JI, McCarthy MI, Morris AP. Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation. Nat Genet (2022).